Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European psychiatry

• Publication date

  2015-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.eurpsy.2015.09.009PMID 26485297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scale for the Assessment of Negative Symptoms

  2014cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Pharmacotherapy of mood disorders.

  2008cited by this paper
• Clinical Recovery in First-Episode Psychosis

  2008cited by this paper
• Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

  2008cited by this paper
• Early Identification and Intervention in Depressive Disorders: Towards a Clinical Staging Model

  2008cited by this paper
• Nontricyclic antidepressants - Predictors of nonadherence

  2007cited by this paper
• Adverse Effects of Atypical Antipsychotics

  2007cited by this paper
• Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages

  2007cited by this paper
• Clinical epidemiologic first‐episode psychosis: 1‐year outcome and predictors

  2007cited by this paper
• Setting the stage: from prodrome to treatment resistance in bipolar disorder.

  2007cited by this paper
• The potential utility of a staging model as a course specifier: a bipolar disorder perspective.

  2007cited by this paper
• Atypical Antipsychotics for the Treatment of Bipolar Disorder

  2007cited by this paper
• Extrapyramidal Adverse Events Associated With Atypical Antipsychotic Treatment of Bipolar Disorder

  2007cited by this paper
• Nontricyclic antidepressants: predictors of nonadherence.

  2006cited by this paper
• Cognitive–behavioural therapy for severe and recurrent bipolar disorders

  2006cited by this paper
• Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

  2006cited by this paper
• Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).

  2006cited by this paper
• Clinical Staging of Psychiatric Disorders: A Heuristic Framework for Choosing Earlier, Safer and more Effective Interventions

  2006cited by this paper
• Pharmacological Treatment in the Early Phase of Bipolar Disorders: What Stage are we at?

  2006cited by this paper
• Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

  2006cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005cited by this paper
• Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients.

  2004cited by this paper
• Comparative effectiveness of antipsychotic drugs.

  2003cited by this paper
• Comparative effectiveness of antipsychotic drugs.

  2003cited by this paper
• A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.

  2003cited by this paper
• Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.

  1999cited by this paper
• Tardive dyskinesia in affective disorders.

  1999cited by this paper
• Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

  1997cited by this paper
• Dsm-IV Casebook: A Learning Companion to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition

  1994cited by this paper
• The Fifth Edition of the Addiction Severity Index.

  1992cited by this paper
• Scale for the Assessment of Negative Symptoms (SANS)*

  1989cited by this paper
• The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients

  1987cited by this paper
• Rapid Induction of Extrapyramidal Side Effects with Combined Use of Lithium and Neuroleptics

  1985cited by this paper
• The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome.

  1984cited by this paper
• Measurement of premorbid adjustment in chronic schizophrenia.

  1982cited by this paper
• Course of the Manic-Depressive Cycle and Changes Caused by Treatments

  1980cited by this paper
• A Rating Scale for Mania: Reliability, Validity and Sensitivity

  1978cited by this paper
• Development of a rating scale for primary depressive illness.

  1967cited by this paper
• Obesity, affect, and therapeutic starvation.

  1967cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview

  2024cites this paper
• A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention

  2023influential citation
• Side-Chain Immune Oxysterols Induce Neuroinflammation by Activating Microglia

  2023cites this paper
• The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

  2022cites this paper
• A narrative review of intervention in first-episode affective psychoses.

  2021cites this paper
• Bipolar disorder.

  2021cites this paper
• [Early intervention in bipolar affective disorders: Why, when and how].

  2021cites this paper
• Personality disorder among youth with first episode psychotic mania: An important target for specific treatment?

  2021cites this paper
• Advances in the psychopharmacotherapy of bipolar disorder type I

  2021cites this paper
• What impact does bipolar disorder staging have on the use of pharmacotherapy?

  2021cites this paper
• Does guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder?

  2020cites this paper
• The case for improved care and provision of treatment for people with first-episode mania.

  2019cites this paper
• Early intervention for bipolar disorder - Do current treatment guidelines provide recommendations for the early stages of the disorder?

  2019cites this paper
• Improving functional outcomes in early‐stage bipolar disorder: The protocol for the REsearch into COgnitive and behavioural VERsatility trial

  2019cites this paper
• Bipolar disorder in the South African private health sector: Longitudinal analysis of prevalence, comorbidities and prescribing patterns

  2019cites this paper
• Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update

  2018cites this paper
• Social and academic premorbid adjustment domains predict different functional outcomes among youth with first episode mania.

  2017cites this paper
• Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.

  2017cites this paper
• Staging in bipolar disorder: from theoretical framework to clinical utility

  2017cites this paper
• Rethinking vulnerable groups in clinical research

  2017cites this paper
• Olanzapine-induced renal damage and metabolic side effects: the protective effect of thymoquinone

  2017cites this paper
• Pozycja wybranych atypowych leków przeciwpsychotycznych w terapii choroby afektywnej dwubiegunowej – obecny stan wiedzy

  2017cites this paper
• Quetiapine v. lithium in the maintenance phase following a first episode of mania: Randomised controlled trial

  2017cites this paper
• First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update

  2017influential citation
• Chapter 5 - Antipsychotic Drugs

  2016cites this paper
• Trajectory and predictors of quality of life in first episode psychotic mania.

  2016cites this paper
• Blue‐blocking glasses as additive treatment for mania: a randomized placebo‐controlled trial

  2016cites this paper